GBS NINDS Diagnostic criteria:
Required
Progressive weakness of more than one limb
Areflexia (typically global, can be distal with preserved proximal reflexes)
Supportive features:
Progression of symptoms over days to four weeks
Relative symmetry
Mild sensory symptoms or signs
Cranial nerve involvement, especially bilateral facial nerve weakness
Recovery starting two to four weeks after progression halts
Autonomic dysfunction
No fever at the onset
Elevated protein in CSF (>45) with a cell count <10 mm3 (“cytoalbuminologic dissociation”)
Electro diagnostic abnormalities consistent with GBS
Features making diagnosis of GBS doubtful:
Sensory level (decrement or loss of sensation below a spinal cord root level as determined by neuralgic examination)
Marked, persistent asymmetry of weakness
Severe and persistent bowel and bladder dysfunction
50 white cells in the CSF
The ddx of GBS includes other acute polyneuropathies, chronic inflammatory demyelinating polyneuropathy (CIDP), and diseases of the spinal cord, neuromuscular junction, and muscle; the ddx of the MFS variant of GBS includes brainstem stroke, encephalitis, Wernicke's encephalopathy